Some restrictions lifted on diabetes drug Avandia

FDA has eased restrictions on patient access to the controversial diabetes drug rosiglitazone (Avandia, GlaxoSmithKline). The agency made its determination after an FDA Advisory Committee reviewed the drug in June 2013 and voted to lift its restrictions, and new information was released indicating that the drug carries no heightened cardiovascular risk. » More

Face-to-face med sync improves adherence

Medication adherence and persistence with chronic medications can be greatly improved with appointment-based medication synchronization, according to a study published in the Journal of the American Pharmacists Association. » More

Foulkes named president of CVS pharmacy

Helena Foulkes, a veteran with more than two decades of experience with CVS Caremark, will become president of the retail chain's pharmacy business effective Jan. 1. » More

Study: Mail-order works well for diabetes patients

Diabetes patients who received heart medications via mail-order were less likely to visit emergency rooms than those who received their prescriptions in person, according to a study in the American Journal of Managed Care. » More

Continuing Education

New CPE mini-series: Multiple sclerosis

This month, Drug Topics offers the first of a two-part CPE series, "MTM considerations in multiple sclerosis." Earn up to 2 credits by completing this knowledge-based activity. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.

Check these out, too

• Infusion site sways specialty drug costs

• President Obama signs compounding act

• Label changes required for OTC antiseptics

• Sandoz to offer generic Solaraze

Voices

Anticoagulation Update